Skip to content

Opening book details…

About this Medicine article

Engineering of NK activating receptor ligands enhances immune compatibility of MHC-Iâ/â iPSC-derived Î2 cells for cell therapy of type 1 diabetes by Chimienti, R.; Baccega, T.; Manenti, F.; Torchio, S.; Pellegrini, S.; Cospito, A.; Monti, P.; Sordi, V.; Lombardo, A.; Malnati, M.; Piemonti, L. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Chimienti, R.; Baccega, T.; Manenti, F.; Torchio, S.; Pellegrini, S.; Cospito, A.; Monti, P.; Sordi, V.; Lombardo, A.; Malnati, M.; Piemonti, L.
Publisher
Informa plc; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1465-3249)
Published
2020
Field
Medicine (Health Sciences)

More by Chimienti, R.; Baccega, T.; Manenti, F.; Torchio, S.; Pellegrini, S.; Cospito, A.; Monti, P.; Sordi, V.; Lombardo, A.; Malnati, M.; Piemonti, L.

Browse all works by Chimienti, R.; Baccega, T.; Manenti, F.; Torchio, S.; Pellegrini, S.; Cospito, A.; Monti, P.; Sordi, V.; Lombardo, A.; Malnati, M.; Piemonti, L.